Elementis Share News (ELM)

LONDON BRIEFING: GSK quarterly sales slip but confirms 2023 guidance

(Alliance News) - Stocks in London were set to open lower on Wednesday as worries about the US banking sector returned.

LONDON BROKER RATINGS: Deutsche Bank cuts Severn Trent to 'hold'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

LONDON BRIEFING: Network International receives another, better offer

(Alliance News) - Stocks in London are set to open lower on Friday, as central bankers on both sides of the Atlantic pointed to further rate hikes and UK retail sales data disappointed.

UK shareholder meetings calendar - next 7 days

DIRECTOR DEALINGS: 888 Chair Jon Mendelsohn buys 100,000 shares

(Alliance News) - The following is a round-up of share dealings by London-listed company directors and managers announced on Monday and not separately reported by Alliance News:

Director dealings: Elementis director makes share purchase

(Sharecast News) - Elementis revealed on Friday that senior independent director Steve Good had acquired 20,000 ordinary shares in the FTSE 250-listed chemicals firm.

Elementis annual loss widens, revenue up as costs increase

(Alliance News) - Elementis PLC on Tuesday said its annual loss widened, while revenue was up as administrative expenses and costs of sales weighed on performance.

Elementis FY pre-tax losses widen on impairment charge

(Sharecast News) - Chemicals business Elementis said on Tuesday that pre-tax losses had widened in the twelve months ended 31 December as a result of a sizeable impairment charge.

UK earnings, trading statements calendar - next 7 days

LONDON BROKER RATINGS: Citigroup cuts Persimmon; HSBC raises Asos

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning:

IN BRIEF: Elementis completes USD119 million sale of chromium business

Elementis PLC - London-based speciality chemicals - Completes USD119 million sale of Chromium business, a producer of chromium chemicals, to Yildirim Group. Back in November, Elementis said it had agreed to sell Chromium to Yildirim, a Dutch-Turkish industrial group headquartered in Istanbul and Amsterdam, for an enterprise value of USD170 million. The transaction includes the transfer of environmental liabilities of USD35 million, and other liabilities of USD8 million, with the total cash proceeds on completion at USD119 million before tax and transaction costs.

IN BRIEF: Elementis expects annual profit to be in line with consensus

Elementis PLC - London-based speciality chemicals - Delivers a "solid performance" during the fourth quarter of 2022, despite "experiencing weaker trading conditions as the macro-economic environment deteriorated through the period". Underlying operating profit for 2022 is expected to be in the range of USD120 million to USD123 million in line with market expectations and significantly ahead of the prior year. Particularly, says Personal Care continued to perform strongly. "In Cosmetics, pricing actions more than offset continuing cost inflation and some weakening of demand in certain regions. AP Actives demand remained robust," Elementis adds. Expects net debt at the end of 2022 to be about USD367 million. Full-year 2022 results will be released on March 7.

Elementis on track to meet FY market views after solid Q4

(Sharecast News) - Specialty chemicals company Elementis said on Thursday that it was on track to meet market expectations for the full year as it hailed a solid fourth-quarter performance.

LONDON BROKER RATINGS: JPMorgan cuts Assura; BofA cuts Synthomer

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

LONDON MARKET CLOSE: European markets in the green; US GDP rises

(Alliance News) - Stock prices in London came to a mixed close on Wednesday, as the FTSE 100 index continued to outperform on the strength of miners and oil stocks.